+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heparin"

From
Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025 - Product Thumbnail Image

Heparin-Induced Thrombocytopenia (HIT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
P Selectin Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

P Selectin Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Medical Heparin Coating Market - Global Forecast 2025-2030 - Product Thumbnail Image

Medical Heparin Coating Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
From
From
Heparin Coatings Market - Global Forecast 2025-2030 - Product Thumbnail Image

Heparin Coatings Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Thrombocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Thrombocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Catastrophic Antiphospholipid Syndrome Market Report 2025 - Product Thumbnail Image

Catastrophic Antiphospholipid Syndrome Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Antiphospholipid Syndrome Treatment Market Report 2025 - Product Thumbnail Image

Antiphospholipid Syndrome Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Pediatric Ischemic Stroke Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Pediatric Ischemic Stroke Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Ischemic Stroke Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Ischemic Stroke Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Pulmonary Embolism Therapeutics Market 2025-2029 - Product Thumbnail Image

Pulmonary Embolism Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 206 Pages
  • Global
From
From
Loading Indicator

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more